Clovis Oncology
CLVS
#10870
Rank
S$15.18 M
Marketcap
S$0.10
Share price
0.00%
Change (1 day)
-95.14%
Change (1 year)

EPS for Clovis Oncology (CLVS)

EPS in 2022 (TTM): S-$2.61

According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is S-$2.44. In 2012 the company made an earnings per share (EPS) of S-$3.86.

EPS history for Clovis Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)S-$2.61
2012S-$3.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.92-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.55-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85-1,734.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.18-476.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
S-$0.12-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA